<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03593577</url>
  </required_header>
  <id_info>
    <org_study_id>7025</org_study_id>
    <nct_id>NCT03593577</nct_id>
  </id_info>
  <brief_title>Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI</brief_title>
  <official_title>Saccular Dilatation, Endolymphatic Hydrops and Vestibular Schwannoma : is Vertigo Really Correlated to the Tumor ? A Retrospective Study Based on FIESTA-C Sequence Using a 3 Tesla MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endolymphatic hydrops is well known of the lay public in its primary form that is Ménière
      disease. Nowadays, the best w ay to approach it in vivo, is to use magnetic resonance imaging
      (MRI).

      However, endolymphatic hydrops don't limit itself to its primary form but cover a whole range
      of pathologies.

      The hypothesis is that patients with vestibular schwannomas are more likely to develop
      secondary saccular hydrops.

      The aim is to compare high-resolution T2-weighted images of the saccule in patients followed
      up for vestibular schwannomas with healthy volunteers and histological sections from cadavers
      in order to identify its changes.

      The secondary purpose of The protocol is to determine if vestibular and audiometric
      abnormalities could be related to this secondary hydrops more specifically than to the tumor
      size and localisation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or absence of height and width of the saccule on MRI.</measure>
    <time_frame>1 hour after the realization of the MRI</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">185</enrollment>
  <condition>Vestibular Schwannoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient having benefited from an MRI with T2 high-resolution 3D sequence (FIESA) in the
        context of the diagnosis of vestibular schwannoma between 2008 and 2017 at the University
        Hospitals of Strasbourg,
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt; 18,

          -  Subject having benefited from an MRI with T2 high-resolution 3D sequence (FIESA) in
             the context of the diagnosis of vestibular schwannoma between 2008 and 2017 at the
             University Hospitals of Strasbourg,

          -  Subject who has agreed to the use of medical data for the purposes of this research.

        Exclusion Criteria:

          -  Refusal of the patient to participate in the study

          -  Insufficient imaging data,

          -  Tumors already treated,

          -  Atypical tumors with uncertain diagnosis, intra-labrinthic or intra-labyrinthine
             schwannomas, concomitant infectious or inflammatory pathology in the middle or inner
             ear.

          -  Impossibility of giving the subject informed information (difficulty understanding the
             subject,)

          -  Subject under the protection of justice

          -  Subject under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Aïna VENKATASAMY,, MD</last_name>
    <phone>33 3 88 12 78 65</phone>
    <email>aina.venkatasamy@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurélie KARCH-GEORGES, MD</last_name>
    <phone>33 3 88 12 78 65</phone>
    <email>aurelie.karch@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Imagerie 1</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aïna VENKATASAMY, MD</last_name>
      <phone>33 3 88 12 78 65</phone>
      <email>aurelie.karch@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aurélie KARCH-GEORGES, MD</last_name>
      <phone>33 3 88 12 78 65</phone>
      <email>aurelie.karch@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Aïna VENKATASAMY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélie KARCH-GEORGES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis VEILLON, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 22, 2018</study_first_submitted>
  <study_first_submitted_qc>July 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2018</study_first_posted>
  <last_update_submitted>July 9, 2018</last_update_submitted>
  <last_update_submitted_qc>July 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Schwannoma</keyword>
  <keyword>saccular dilatation</keyword>
  <keyword>endolymphatic hydrops</keyword>
  <keyword>magnetic resonnance imaging</keyword>
  <keyword>vertigo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurilemmoma</mesh_term>
    <mesh_term>Neuroma, Acoustic</mesh_term>
    <mesh_term>Endolymphatic Hydrops</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

